Article
Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat-inhibited Dopamine Transport.
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology - 1 Dec 2021
Quizon Pamela M, Yuan Yaxia, Zhu Yike, Zhou Yi, Strauss Matthew J, Sun Wei-Lun, Zhan Chang-Guo, Zhu Jun
Abstract excerpt
HIV-1 transactivator of transcription (Tat) has a great impact on the development of HIV-1 associated neurocognitive disorders through disrupting dopamine transmission. This study determined the mutational effects of human dopamine transporter (hDAT) on basal and Tat-induced inhibition of dopamine transport. Compared to wild-type hDAT, the maximal velocity (Vmax) of [3H]dopamine uptake was decreased in D381L and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
